https://www.pharmanow.live/latest-news/data-integrity-not-scale-is-indias-real-competitive-advantage-chakravarthi-avps-on-indias-pharma-leadership-at-gpacts-2026 2026-09-05T10:45:16+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 Data Integrity, Not Scale, Is India's Real Competitive Advantage - Chakravarthi AVPS on India's Pharma Leadership at GPACTS 2026 GPACTS 2026, Chakravarthi AVPS, data integrity, pharma IT, ALCOA+, FDA compliance, AI in pharma manufacturing, serialization, Pharma Now, YellowHive Events & Media https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/chakravarthi_avps_keynote_press_release20260905101217.png https://www.pharmanow.live/latest-news/fda-emergency-compounding-guidance-neonatal-parenteral-nutrition-outsourcing-facility-shutdown 2026-09-05T10:52:36+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 FDA Issues Emergency Guidance After Neonatal PN Supply Shutdowns FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/31144cca-289b-46a7-8933-6a84dacc2dac/06a87ebb-1d48-4c86-a0ce-f08d2912c893.png https://www.pharmanow.live/latest-news/novartis-pelacarsen-fails-phase-iii-lpa-horizon-cardiovascular-outcomes-trial 2026-09-05T10:51:22+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 Novartis Pelacarsen Fails Phase III Lp(a) Trial Novartis https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/31144cca-289b-46a7-8933-6a84dacc2dac/93b0f050-ef26-4670-982b-c0a504ac6908.png https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-camizestrant-esr1-mutation-breast-cancer 2026-09-05T10:51:25+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 AstraZeneca Wins FDA Approval for Camizestrant in Breast Cancer AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/31144cca-289b-46a7-8933-6a84dacc2dac/49f8c10e-4f5e-439f-935c-5f5da57cc2c8.png https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-camizestrant-cdk46-esr1-mutated-breast-cancer 2026-09-05T22:13:41+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 AstraZeneca Wins FDA Accelerated Nod for Camizestrant AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/31144cca-289b-46a7-8933-6a84dacc2dac/1a114dc3-5557-4370-8d16-882fb7e68315.png https://www.pharmanow.live/latest-news/fda-flags-zubb-dietary-supplement-hidden-sildenafil-weight-loss 2026-09-05T10:50:00+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 FDA Flags ZUBB Supplement for Hidden Sildenafil FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/98af20de-8ff4-46c1-980d-23944177d232/cf9eb7bb-35d1-4a26-aed2-bd9cbd255283.png https://www.pharmanow.live/latest-news/tarsus-pharmaceuticals-acquires-alkeus-pharmaceuticals-alk-001-stargardt 2026-09-04T22:18:32+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Tarsus Acquires Alkeus, Adds Phase 3 Stargardt Drug Tarsus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f48f05bc-2c0d-47e1-bb45-c5c3bd586fe6/072421b7-6f12-4d89-abaa-c38a174b481d.png https://www.pharmanow.live/latest-news/teva-gains-investment-grade-status-sp-upgrade-bbb-minus 2026-09-04T22:24:39+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Teva Gains Investment-Grade Status from All Three Major Rating Agencies After S&P Upgrade https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f48f05bc-2c0d-47e1-bb45-c5c3bd586fe6/04fb8233-b54b-4595-8fc0-4c7ea07ee32f.png https://www.pharmanow.live/latest-news/fda-cber-biologics-regulatory-resource-hub-bla-compliance 2026-09-04T22:25:29+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 FDA CBER Consolidates Biologics Regulatory Resource Hub for BLA and Compliance Teams FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f48f05bc-2c0d-47e1-bb45-c5c3bd586fe6/51764277-0d78-4ca0-a2af-53bf97bcc92c.png https://www.pharmanow.live/latest-news/peptides-complex-generics-symposium-2026-returns-to-mumbai 2026-09-04T18:24:43+05:30 Pharma Now en 2026-09-04T18:24:38+05:30 Peptides & Complex Generics Symposium 2026 Returns to Mumbai Peptides & Complex Generics Symposium 2026, PCG 2026, peptide therapeutics, complex generics, https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/image(1)20260904181315.png https://www.pharmanow.live/latest-news/astrazeneca-hutchmed-tagrisso-orpathys-phase-iii-nsclc-china 2026-09-04T22:26:44+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 AstraZeneca, HUTCHMED Win Phase III NSCLC Trial AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/f92207c6-f6a6-451c-92d2-c414d59fb52d.png https://www.pharmanow.live/latest-news/weave-bio-takeda-ai-regulatory-platform-14-drug-programs 2026-09-04T22:27:48+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Weave Bio and Takeda Deploy AI Regulatory Platform Across 14 Drug Programs Weave https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/d4af46b9-588b-43a5-a3d4-a2db603820c8.png https://www.pharmanow.live/latest-news/abbvie-etentamig-phase-3-multiple-myeloma-60-percent-progression-risk-reduction 2026-09-04T22:29:25+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 AbbVie Achieves 60% Progression Risk Reduction for Etentamig in Phase 3 Multiple Myeloma Trial https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/7db887e0-abe6-4935-90d8-8c74af0ef460.png https://www.pharmanow.live/latest-news/cipla-qilu-pembrolizumab-biosimilar-us-deal 2026-09-04T22:24:05+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Cipla Signs Qilu Deal to Launch Pembrolizumab Biosimilar in U.S. Cipla https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/f502ce66-5ad3-449c-b64c-f8b2fb9bcccd.png https://www.pharmanow.live/latest-news/ema-resolves-visudyne-shortage-new-eu-manufacturing-sites-verteporfin 2026-09-04T22:31:48+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 EMA Resolves Visudyne Shortage After Registering New EU Manufacturing Sites for Verteporfin EMA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/6a545ce4-c1a6-4cdd-9844-d5791a5e6d81.png https://www.pharmanow.live/latest-news/ema-prac-injectable-iron-safety-review-hypophosphataemia-bone-risk-2026 2026-09-04T22:28:23+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 EMA PRAC Launches Safety Review of Injectable Iron Medicines Over Hypophosphataemia and Bone Risk EMA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/0210ac02-8bcb-4749-91bb-9a568f81345d.png https://www.pharmanow.live/latest-news/cms-dermavon-nmpa-approval-lumirix-atopic-dermatitis 2026-09-04T22:30:28+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 CMS's Dermavon Gains NMPA Approval for Lumirix in Pediatric Atopic Dermatitis CMS https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4caaf01a-103e-4eea-97df-2c2ed7979271/88ca0d2d-3d69-4671-a0cc-e429847cec20.png https://www.pharmanow.live/latest-news/agilent-launches-icp-ms-gc-systems-digital-lab-platform-india 2026-09-04T10:46:30+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Agilent Launches ICP-MS, GC Systems and Digital Lab Platform Agilent https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/70e0237d-c086-43bf-8960-5e8af717b7be.png https://www.pharmanow.live/latest-news/cohance-lifesciences-18-million-nj-bio-aruka-bio-adc-manufacturing 2026-09-04T10:46:30+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Cohance Lifesciences Secures $18M Stake in NJ & Aruka Bio Cohance Lifesciences https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/528c1cec-f162-4b87-92e4-11f2a017005e.png https://www.pharmanow.live/latest-news/rpg-life-sciences-acquires-raghava-life-sciences-api-business 2026-09-04T10:46:30+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 RPG Life Sciences Acquires Raghava Life Sciences API Business RPG Life Sciences https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/2542da71-85c2-4487-9fcd-37cbb2880110.png https://www.pharmanow.live/latest-news/american-regent-epinephrine-recall-particulate-sterility-2026 2026-09-04T10:46:29+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 American Regent Recalls Three Epinephrine Lots Over Cracked Vials American Regent https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/fa50f240-e3fa-4a9d-9e36-2b2a13e6ee98.png https://www.pharmanow.live/latest-news/axcelead-fda-nams-road-map-seminar-ind-submission-strategy 2026-09-04T10:47:55+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Axcelead Releases FDA NAMs Road Map Seminar on IND Strategy Axcelead https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://axcelead-us.com/wp-content/uploads/2026/09/20260904-Webinar-TIM-1.png https://www.pharmanow.live/latest-news/cipla-invagen-qilu-keytruda-biosimilar-us-deal 2026-09-04T10:46:33+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Cipla InvaGen Signs Biosimilar Deal with Qilu for US Market Cipla https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/b0b615a9-a8e7-4fe5-8c61-21a1df9d210f.png https://www.pharmanow.live/latest-news/pendopharm-cda-amc-conditional-reimbursement-yorvipath-chronic-hypoparathyroidism 2026-09-04T10:51:05+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Pendopharm Secures AMC Reimbursement Nod for Yorvipath Pendopharm https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/54fc8afb-c164-4d78-93f3-dff346091b3b/49f0e6be-51c7-46e6-a0c3-f7cc62dd8387.png https://www.pharmanow.live/latest-news/cber-regulatory-framework-allergenic-products-biologics 2026-09-04T10:56:01+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 CBER Maintains Framework for Three Allergenic Products CBER https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/54fc8afb-c164-4d78-93f3-dff346091b3b/4f2d8a80-67b8-4482-b441-0eda2b02799a.png https://www.pharmanow.live/latest-news/fda-approves-zanvastro-first-treatment-alexander-disease 2026-09-04T10:57:04+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 FDA Approves Zanvastro as First Treatment for Alexander Disease FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/54fc8afb-c164-4d78-93f3-dff346091b3b/c79a4398-47ea-4071-b04a-2dad7c6a2d76.png